Subtotal: $200.00
Retatrutide 5mg
$150.00
Retatrutide is an emerging tri-agonist peptide of interest in metabolic and weight management research. Classified as a GGG agonist, it activates three key receptors: GLP-1, GIP, and the glucagon receptor. This multi-receptor activity is being studied for its potential to drive both appetite suppression and increased energy expenditure. Preliminary research suggests that Retatrutide may offer some of the most significant weight reduction effects observed in peptide studies to date, with reported reductions in total body weight reaching up to 24%. Its mechanisms are believed to involve enhanced metabolic rate through glucagon receptor activation, combined with central and peripheral appetite regulation.
In Stock
Description
Retatrutide
Research Peptide Compound
Retatrutide is a novel multi-agonist peptide being studied for its unique potential in metabolic research. It acts on the GLP-1, GIP, and glucagon receptors, making it a subject of interest for research focused on glucose regulation, energy balance, and body composition modulation.
Researchers are exploring its extended half-life and synergistic receptor activity for its potential to support enhanced metabolic signaling pathways compared to single-receptor analogs.
Research Highlights
-
Investigated for its ability to regulate appetite and energy expenditure
-
Studied for its effects on insulin sensitivity and glucose tolerance
-
Explored for potential fat oxidation and body weight modulation
-
Designed to activate GLP-1, GIP, and glucagon receptors in a single molecule
Compound Format: 5mg lyophilized powder
Purity: ≥98%
Storage: Store lyophilized peptide at -20°C. Reconstituted solution should be refrigerated.
This compound is intended for laboratory research use only. It is not approved for human or veterinary use.
Reviews
There are no reviews yet.